Select a State

Global health R&D delivers for Michigan

US government investment in global health R&D has delivered

$51.9 million
to Michigan research institutions
700+ new jobs
for Michigan

Neglected diseases in Michigan

Chikungunya cases
37
Dengue cases
77
HIV diagnoses
6,932
Malaria cases
189
Tuberculosis cases
1,343
West Nile cases
381
Zika cases
74

Michigan's top USG-funded global health R&D institutions

University of Michigan
$26.6 million
Michigan State University
$23.5 million
Wayne State University
$1.4 million
University of Central Michigan
$420 thousand

Michigan industry in global health R&D

AbbVie
Location(s):
Wyandotte
Bayer
Location(s):
Muskegon
Emergent Biosolutions
Location(s):
Lansing
NanoBio
Location(s):
Ann Arbor
Vestaron Corporation
Location(s):
Kalamazoo

Michigan's top areas of global health R&D by USG funding

7.4%
HIV/AIDS
32.5%
Malaria
14.8%
Tuberculosis
21.0%
Diarrheal diseases
13.0%
Neglected tropical diseases
Buruli ulcer
Dengue
Helminths
Kinetoplastids
11.2%
Other
Non-allocable
Salmonella infections

Global health R&D at work in Michigan

Michigan State University (MSU) researchers are developing a low-cost skin patch that can rapidly and safely detect malaria. Current diagnostics for malaria generally require blood; the patch will render this unnecessary via an array of microneedles that painlessly collect fluid from just beneath the skin’s surface, an area known to contain proteins from the malaria parasite in infected individuals. This sample will then be transferred to a test that would indicate a positive diagnosis with colored lines. The MSU team aims to develop a prototype for preliminary evaluation. Each year, malaria kills almost half a million people, mostly young children in Africa.

Footnotes